Featured Research

from universities, journals, and other organizations

Washington pediatricians receive regular requests for alternative child immunization schedules

Date:
November 28, 2011
Source:
Seattle Children's
Summary:
Seventy-seven percent of Washington state pediatricians report that they are sometimes or frequently asked to provide alternative childhood vaccine schedules for their patients, according to a new study.

Seventy-seven percent of Washington state pediatricians report that they are sometimes or frequently asked to provide alternative childhood vaccine schedules for their patients, according to a new study from Seattle Children's Research Institute. Researchers also found that 61 percent of Washington state pediatricians are comfortable using an alternative schedule when asked by a parent.

The study is published in the December 2011 issue of Pediatrics and is the first to evaluate pediatricians' attitudes towards alternative schedules.

"When discussing alternative childhood immunization schedules, pediatricians have to balance two things: respecting the parents' decision and protecting the health of the child," said Doug Opel, MD, MPH, bioethicist at Seattle Children's Research Institute and a University of Washington acting assistant professor of pediatrics. "This is a difficult and important discussion, and what we found was that most pediatricians are comfortable being flexible with the immunization schedule when parents ask for this flexibility."

The group of 209 pediatricians included in the study were least willing to revise the schedule for three vaccinations: diphtheria-tetanus toxoids-acellular pertussis vaccine (DTaP), Haemophilus influenzae type b vaccine (Hib) and pneumococcal conjugate vaccine (PCV). This suggests physicians want to prioritize immunizations that protect against some of the most common and most dangerous diseases which may occur during infancy and early childhood. Skipping the DTaP vaccine, for example, could lead to pertussis, also known as whooping cough. Pertussis is still common in the U.S. with frequent outbreaks. The Hib and PCV vaccines protect against infections like meningitis and pneumonia.

"The study demonstrates the need for more research on the use of alternative immunization schedules and the safety, efficacy and consequences of delaying immunizations," said Dr. Opel. Seattle Children's Research Institute will continue to study this topic to better understand the effect of childhood immunization schedules on individuals and public health.

Dr. Opel's co-authors were: Aaron Wightman, MD, Seattle Children's Research Institute and University of Washington; Edgar Marcuse, MD, MPH, Seattle Children's Research Institute and University of Washington and James Taylor, MD, University of Washington.


Story Source:

The above story is based on materials provided by Seattle Children's. Note: Materials may be edited for content and length.


Journal Reference:

  1. Aaron Wightman, Douglas J. Opel, Edgar K. Marcuse, James A. Taylor. Washington State Pediatricians' Attitudes Toward Alternative Childhood Immunization Schedules. Pediatrics, 2011; DOI: 10.1542/peds.2011-0666

Cite This Page:

Seattle Children's. "Washington pediatricians receive regular requests for alternative child immunization schedules." ScienceDaily. ScienceDaily, 28 November 2011. <www.sciencedaily.com/releases/2011/11/111128152420.htm>.
Seattle Children's. (2011, November 28). Washington pediatricians receive regular requests for alternative child immunization schedules. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2011/11/111128152420.htm
Seattle Children's. "Washington pediatricians receive regular requests for alternative child immunization schedules." ScienceDaily. www.sciencedaily.com/releases/2011/11/111128152420.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins